Inscripta: Funding, Investors & Team (Aug 2026)
With the first benchtop system for genome editing, Inscripta, a life science technology business, enables researchers to address some of the most important problems of the day. With the company's automated OnyxTM platform, which consists of an instrument, consumables, tests, and software, any research centre may use CRISPR to modify the genome. From offices in Boulder, Colorado; San Diego, Pleasanton, Calif.; Copenhagen, Denmark; and Pleasanton, Calif., Inscripta provides support for its clients around the world. Visit Inscripta.com and follow @InscriptaInc for more information.
Inscripta has raised $154M across 2 funding rounds on record, the most recent an undisclosed round of $4.4M announced in Jan 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Inscripta Company Profile and Key Stats
Latest funding round on record: Jan 2023.
Inscripta Funding Rounds
Inscripta raised $150M in a Series E announced in Apr 2021.
1.8 years later, an undisclosed round of $4.4M was announced in Jan 2023.
Inscripta Founders and Leadership Team
Contact details for the Inscripta team: 2 of 2 have an email address on file.
Start 14-day free trial →Inscripta Funding Compared to Other Biotechnology Startups
Inscripta's latest round of $4.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Inscripta in Biotechnology and Boulder
Companies Similar to Inscripta
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Inscripta Funding FAQs
What does Inscripta do?
With the first benchtop system for genome editing, Inscripta, a life science technology business, enables researchers to address some of the most important problems of the day. With the company's automated OnyxTM platform, which consists of an instrument, consumables, tests, and software, any research centre may use CRISPR to modify the genome. From offices in Boulder, Colorado; San Diego, Pleasanton, Calif.; Copenhagen, Denmark; and Pleasanton, Calif., Inscripta provides support for its clients around the world. Visit Inscripta.com and follow @InscriptaInc for more information.
How much funding has Inscripta raised?
Inscripta has raised $154M across 2 rounds on record. The most recent is an undisclosed round of $4.4M announced in Jan 2023.
When did Inscripta last raise funding?
Inscripta's most recent funding round on record is an undisclosed round of $4.4M, announced in Jan 2023.
Who founded Inscripta?
FundedIQ lists Andrew Garst (Founder) at Inscripta.
Who is the CEO of Inscripta?
Sri Kosaraju is listed as CEO at Inscripta.
Where is Inscripta headquartered?
Inscripta is based in Boulder, Colorado, United States.
How many employees does Inscripta have?
Inscripta is in the 101-250 employee band.
How does Inscripta's funding compare to other Biotechnology startups?
Inscripta's latest round of $4.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Inscripta Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Inscripta is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.